Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1016/j.metabol.2009.07.029. Epub 2009 Oct 1.
Jing Wei, Rong Xue, Jin-Dan Wu, Wei Zhao, Zi-Zheng Wang, Shu-Kui Wang, Zheng-Xian Zhou, Dan-Qing Song, Yue-Ming Wang, Huai-Ning Pan, Wei-Jia Kong, Jian-Dong Jiang
Affiliations
- PMID: 19800084
- DOI: 10.1016/j.metabol.2009.07.029
Randomized Controlled Trial
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Hao Zhang et al. Metabolism. 2010 Feb.
Abstract
Our previous work demonstrated that berberine (BBR) increases insulin receptor (InsR) expression and improves glucose utility both in vitro and in animal models. Here, we study the InsR-up-regulating and glucose-lowering activities of BBR in humans. Our results showed that BBR increased InsR messenger RNA and protein expression in a variety of human cell lines, including CEM, HCT-116, SW1990, HT1080, 293T, and hepatitis B virus-transfected human liver cells. Accordingly, insulin-stimulated phosphorylations of InsR beta-subunit and Akt were increased after BBR treatment in cultured cells. In the clinical study, BBR significantly lowered fasting blood glucose (FBG), hemoglobin A(1c), triglyceride, and insulin levels in patients with type 2 diabetes mellitus (T2DM). The FBG- and hemoglobin A(1c)-lowering efficacies of BBR were similar to those of metformin and rosiglitazone. In the BBR-treated patients, the percentages of peripheral blood lymphocytes that express InsR were significantly elevated after therapy. Berberine also lowered FBG effectively in chronic hepatitis B and hepatitis C patients with T2DM or impaired fasting glucose. Liver function was improved greatly in these patients by showing reduction of liver enzymes. Our results confirmed the activity of BBR on InsR in humans and its relationship with the glucose-lowering effect. Together with our previous report, we strongly suggest BBR as an ideal medicine for T2DM with a mechanism different from metformin and rosiglitazone.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
- Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD. Kong WJ, et al. Metabolism. 2009 Jan;58(1):109-19. doi: 10.1016/j.metabol.2008.08.013. Metabolism. 2009. PMID: 19059538 - Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L. Wang Y, et al. Metabolism. 2011 Feb;60(2):298-305. doi: 10.1016/j.metabol.2010.02.005. Epub 2010 Mar 20. Metabolism. 2011. PMID: 20304443 - Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
Strowig SM, Raskin P. Strowig SM, et al. Diabetes Obes Metab. 2005 Nov;7(6):633-41. doi: 10.1111/j.1463-1326.2004.00440.x. Diabetes Obes Metab. 2005. PMID: 16219007 Review. - Initiating insulin in patients with type 2 diabetes.
Aoki TJ, White RD. Aoki TJ, et al. J Fam Pract. 2007 Aug;56(8 Suppl Hot Topics):S12-20. J Fam Pract. 2007. PMID: 18667139 Review.
Cited by
- Fructus mume formula in the treatment of type 2 diabetes mellitus: a randomized controlled pilot trial.
Tu X, Xie C, Wang F, Chen Q, Zuo Z, Zhang Q, Wang X, Zhong S, Jordan JB. Tu X, et al. Evid Based Complement Alternat Med. 2013;2013:787459. doi: 10.1155/2013/787459. Epub 2013 Mar 7. Evid Based Complement Alternat Med. 2013. PMID: 23533521 Free PMC article. - Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.
Dong H, Wang N, Zhao L, Lu F. Dong H, et al. Evid Based Complement Alternat Med. 2012;2012:591654. doi: 10.1155/2012/591654. Epub 2012 Oct 15. Evid Based Complement Alternat Med. 2012. PMID: 23118793 Free PMC article. - Effect of Huang-Lian Jie-Du Decoction on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Hu Z, Yang M, Liu Y, Yang Q, Xie H, Peng S, Gao J, Xie C. Hu Z, et al. Front Pharmacol. 2021 Apr 29;12:648861. doi: 10.3389/fphar.2021.648861. eCollection 2021. Front Pharmacol. 2021. PMID: 33995064 Free PMC article. - Insulin resistance: Is it time for primary prevention?
Mercurio V, Carlomagno G, Fazio V, Fazio S. Mercurio V, et al. World J Cardiol. 2012 Jan 26;4(1):1-7. doi: 10.4330/wjc.v4.i1.1. World J Cardiol. 2012. PMID: 22279598 Free PMC article. - Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study.
Liu L, Yu YL, Yang JS, Li Y, Liu YW, Liang Y, Liu XD, Xie L, Wang GJ. Liu L, et al. Naunyn Schmiedebergs Arch Pharmacol. 2010 Apr;381(4):371-81. doi: 10.1007/s00210-010-0502-0. Epub 2010 Mar 13. Naunyn Schmiedebergs Arch Pharmacol. 2010. PMID: 20229011
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous